Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
2021年9月7日 - 8:45PM
ビジネスワイヤ(英語)
Catalent, Inc. (NYSE: CTLT), the leading global provider of
development sciences and manufacturing platforms for medicines,
including biotherapeutics; cell and gene therapies; and consumer
health products, today announced that members of its executive
leadership team will virtually present at the Morgan Stanley 19th
Annual Global Healthcare Conference at 1:15 a.m. ET on September 9,
2021.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc. Catalent Inc. [NYSE: CTLT], an
S&P 500® company, is the leading global provider of development
sciences and manufacturing platforms for medicines, including
biotherapeutics; cell and gene therapies; and consumer health
products. With almost 90 years serving the industry, Catalent has
proven expertise in bringing more customer products to market
faster, enhancing product performance, and ensuring reliable global
clinical and commercial product supply. Catalent’s workforce
exceeds 17,000 people, including more than 2,500 scientists and
technicians, at more than 50 facilities on four continents, and in
fiscal year 2021, it generated $4 billion in annual revenue.
Catalent is headquartered in Somerset, New Jersey. For more
information, please visit www.catalent.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210907005041/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
過去 株価チャート
から 6 2024 まで 7 2024
Catalent (NYSE:CTLT)
過去 株価チャート
から 7 2023 まで 7 2024